概括
良性前列腺增大 (BPH) 是一种常见的前列腺扩大,影响老年男性. 未经治疗的BPH会导致严重的尿路和脏并发症,需要及时的医疗干预.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 老年病的医生 老年病的医生
- 公共卫生 公共卫生
背景情况:
- 良性前列腺增大 (BPH) 是前列腺的非癌症扩大.
- 这是一种与衰老相关的常见疾病,影响了男性人口的很大一部分.
- 从2000年到2019年,全球BPH发病率增加了70%,突出显示了其对公共健康的影响日益增加.
研究的目的:
- 概述良性前列腺增大的原因和后果.
- 审查BPH的可用治疗选择.
- 为医疗保健提供者和患者提供关于BPH管理的全面信息.
主要方法:
- 这篇文章是对BPH现有的文献和临床知识的综述.
- 它综合了关于BPH病理生理学,临床表现和管理策略的信息.
- 没有产生新的临床数据;重点是总结当前的理解.
主要成果:
- 乙PH是一种与衰老相关的渐进性疾病.
- 未经治疗的BPH可能会导致严重的并发症,包括急性尿,反复发作的尿路感染,膀结石,脏损伤和出血症.
- 有各种不同的治疗选择,从警等待到医疗和手术干预.
结论:
- 良性前列腺增大是一种普遍的疾病,如果不加以管理,可能会导致严重的发病.
- 早期识别症状和适当的治疗对于预防严重的健康后果至关重要.
- 了解BPH的原因,后果和治疗环境对于有效的患者护理至关重要.
相关概念视频
Disorders of the Male Reproductive System
474
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
474
Hypertension III: Clinical Manifestations and Diagnostic Studies
33
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
33
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
197
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
197
Hypertension IV: Drug Therapy and Lifestyle Modifications
19
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
19
Urinary Tract Calculi III: Medical Management
9
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
9
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
212
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
212


